You searched for: cancer
1 to 10 of 280 results
Show
results per page
-
Associate Professor
School of Public HealthFaculty of MedicineMatched phrases in profile:
I research the aetiology of ovarian, endometrial and thyroid cancers. I am particularly interested… Pathways to the diagnosis of epithelial ovarian cancer in Australia (Med J Aust 2010; 193: 326-330)… National Pancreatic Cancer Roadmap Early Implementation Priorities: Developing tools and guidelines for early diagnosis of pancreatic cancer… such as ischaemic heart disease (IHD) and cancer. Despite this, the long-term health effects of these… Cancer epidemiology… Dr Jordan is a medically trained cancer epidemiologist who is currently Associate Professor of… Although some high-risk ovarian cancer genes have been identified, it is likely that common low…
Medical and Health Sciences; Oncology and Carcinogenesis; Paediatrics and Reproductive Medicine; Public Health and Health Services; Obstetrics and Gynaecology; Epidemiology;- Email:
- s.jordan@uq.edu.au
- Ph:
- +61 7 336 55473
Dr Jordan is a medically trained cancer epidemiologist who is currently Associate Professor of Epidemiology at the School of Public Health. Before starting her PhD, she worked in rural and urban general practice for over 10 years and brings that clinical experience to her research. She currently lea …
Dr Jordan's impacts contributions include: 1) the first comprehensive aetiological study to support the paradigm-shifting contention that most ovarian cancers arise in fallopian tubes rather than ovaries; 2) research on variations in ovarian cancer chemotherapy prompted revision of current ovarian …
-
Lecturer
School of Public HealthFaculty of MedicineMatched phrases in profile:
I am a cancer epidemiologist with a focus on women’s cancers (breast, gynaecological) and… Health-related quality of life 18 months after breast cancer: comparison with the general population of Queensland, Australia… Endometrial cancer patient experiences: a cross-sectional pilot study… cancer epidemiology… Division of the School of Public Health. Dr Di Sipio is an experienced cancer epidemiologist with a… Background: The adverse consequences of lymphedema following breast cancer in relation to physical…
Medical and Health Sciences; Oncology and Carcinogenesis; Oncology and Carcinogenesis not elsewhere classified; Health Sciences; Epidemiology; Public health;- Email:
- t.disipio@uq.edu.au
- Ph:
- +61 7 344 36167
Dr Tracey Di Sipio is a teaching and research academic in the Epidemiology and Biostatistics Division of the School of Public Health. Dr Di Sipio is an experienced cancer epidemiologist with a focus on women’s cancers, caregivers, and health equity.
-
NHMRC Leadership Fellow
UQ Centre for Clinical ResearchFaculty of MedicineMatched phrases in profile:
The LACE study is a clinical trial comparing two types of surgery for women with early-stage cancer… Cancer specialists are aware that not only the survival time but also the quality of life is a key… The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: A retrospective study… feMMe: Uterus-preserving treatment of endometrial cancer… Prophylactic surgery and breast cancer… levonorgestrel intrauterrine device (LNG-IUD) to treat endometrial cancer. The next two steps… Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC… Background: Serum CA125 is routinely used in the follow up of ovarian cancer. The objective of the…
Biological Sciences; Medical and Health Sciences; Medical Microbiology; Oncology and Carcinogenesis; Paediatrics and Reproductive Medicine; Public Health and Health Services; Cancer Diagnosis; Obstetrics and Gynaecology; Health Sciences; Biomedical and Clinical Sciences; Oncology and carcinogenesis; Medical microbiology; Biological Sciences;- Email:
- a.obermair@uq.edu.au
- Ph:
- +61 7 334 66044
Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC Research). He is a Professor of Gynaecological Oncology since 2007, a Senior Medical Officer at Royal Brisbane & Women’s Hospital and a Visiting Medical Officer at St Andrews War Memorial Hospital and …
Professor Obermair is an innovative and skilled gynaecologic oncologist, surgical teacher and consumer advocate. His international leadership and research impact was acknowledged in 2020 by the Australian community, when he was awarded an NHMRC Investigator Fellowship Level 2 (2021-25). The national …
-
ATH - Professor
Mater Clinical UnitFaculty of MedicineMatched phrases in profile:
MPS and cancer prognosis, circulating fDNA, Sentinel Node biopsy trials Breast Cancer Audit and cancer registries… Is parathyroid hormone-related protein a sensitive serum marker in advanced breast cancer?… Whole Genome Sequencing in high-risk breast cancer patients.… Breast Cancer… University of Nottingham(UK) and Mayo Clinic (USA) Chairman, Foundation for Breast Cancer Care… Background: To compare already used serum markers in advanced breast cancer, namely erythrocyte…
Oncology and Carcinogenesis; Cancer Therapy (excl. Chemotherapy and Radiation Therapy); Medical and Health Sciences; Cancer therapy (excl. chemotherapy and radiation therapy); Oncology and carcinogenesis; Biomedical and Clinical Sciences;- Email:
- c.pyke@uq.edu.au
Breast and Endocrine Surgeon, Mater Hospitals South Brisbane.
Previous Fellowships at University of Nottingham(UK) and Mayo Clinic (USA)
Chairman, Foundation for Breast Cancer Care
Senior Surgeon Breast Screen Qld Metro south Brisbane
Breast Cancer Quality Audit - >140,000 entries , identiying gaps in service delivery to Breast Cancer patients
-
NHMRC Emerging Leadership Fellow
Australian Institute for Bioengineering and NanotechnologyMatched phrases in profile:
eMethylsorb: rapid quantification of DNA methylation in cancer cells on screen-printed gold electrodes… A potential pan-cancer diagnostic utilizing DNA methylation landscapes… expression pathways leading to diseases like cancer. Thus, DNA methylation has been regarded as one of the… Queensland, Australia. Prior to this, he served as a Visiting Scientist at the Dana-Farber Cancer Institute… DNA methylation has the potential to be a clinically important biomarker in cancer. This…
Chemical Sciences; Technology; Medical and Health Sciences; Oncology and Carcinogenesis; Analytical Chemistry; Medicinal and Biomolecular Chemistry; Medical Biotechnology; Nanotechnology; Cancer Diagnosis; Molecular Targets; Electroanalytical Chemistry;- Email:
- a.sina@uq.edu.au
- Ph:
- +61 7 334 64176
Dr Abu Sina is currently an NHMRC Emerging Leader Fellow at the Center for Personalized Nanomedicine, Australian Institute for Bioengineering & Nanotechnology (AIBN), The University of Queensland, Australia. Prior to this, he served as a Visiting Scientist at the Dana-Farber Cancer Institute, Harvar …
Dr. Sina's research is centered on the development of nanotechnologies for applications in liquid biopsy, addressing clinical challenges in medical diagnostics and precision oncology. His expertise spans diverse areas of basic and translational research, encompassing chemistry, molecular biology, na …
-
Honorary Professor
Mater Research Institute-UQFaculty of MedicineMatched phrases in profile:
Our focus is on the identification and evaluation of molecular targets and biomarkers of cancer. As… Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines… Cellular targets for cancer detection and treatment… A novel molecular pathway in cancer… antigens that are suitable targets for delivery of radioactive and cytotoxic payloads to cancers… Cancers of the reproductive system and gastrointestinal tract… (Cancer Pathology) University of Queensland 1999-00 Post-Doctoral Fellow, Queensland… marker for prostate cancer (PCa). Other members of the KLK family are also emerging as potential…
- Email:
- john.hooper@mater.uq.edu.au
1991-94 BSc Honours I (Chemistry) University of Queensland, University Medal
1995-99 PhD (Cancer Pathology) University of Queensland
1999-00 Post-Doctoral Fellow, Queensland University of Technology
2001-03 NHMRC CJ Martin/RG Menzies Fellow, Scripps Research Institute, San Diego, CA, USA
2003-05 …
My major research contributions are in the identification and evaluation of molecular targets and biomarkers for cancers of the ovary, pancreas, prostate and bowel. At a molecular level my focus is on cell surface receptors, proteolytic enzymes, intracellular signal transducers, mediators of metabol …
-
Honorary Associate Professor
School of Biomedical SciencesFaculty of MedicineMatched phrases in profile:
Primarily endometrial cancer… Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer… Identifying the regulatory targets of common endometrial cancer risk variants… We and our international Endometrial Cancer Association Consortium collaborators have identified… Gynaecological cancer genetics… -enzyme fusion proteins for cancer therapy. He returned to New Zealand to carry out his PhD research… Excessive exposure to estrogen is a well-established risk factor for endometrial cancer (EC…
Biological Sciences; Genetics; Epigenetics (incl.Genome Methylation and Epigenomics); Gene Expression (incl. Microarray and other genome-wide approaches); Genome Structure and Regulation; Quantitative Genetics (incl. Disease and Trait Mapping Genetics); Biomedical and Clinical Sciences; Oncology and carcinogenesis; Molecular targets; Cancer genetics; Gene mapping; Genome structure and regulation; Gene expression (incl. microarray and other genome-wide approaches); Epigenetics (incl. genome methylation and epigenomics); Genetics; Biological Sciences;- Email:
- d.glubb@uq.edu.au
After completing his BSc and MSc (Hons) at the University of Canterbury (NZ), Dylan worked for five years as a Research Scientist at Antisoma Research Limited (London, UK), developing antibody-enzyme fusion proteins for cancer therapy. He returned to New Zealand to carry out his PhD research into an …
Large numbers of germline genetic variants have been found to associate with disease. A major roadblock in our understanding of how genetics contribute to disease has been a lack of knowledge of the molecular effects of variants. Thus, the aim of my research program is to use genetic analyses to ass …
-
Principal Research Fellow
School of Chemical EngineeringFaculty of Engineering, Architecture and Information TechnologyGroup Leader
Australian Institute for Bioengineering and NanotechnologyMatched phrases in profile:
Extracellular vesicle-based drug delivery systems for cancer treatment… PhD projects in cardiovascular inflammation and cancer… Australia-United States Breast Cancer Consumer Workshop in Queensland… contribution of extracellular vesicles in breast cancer immunoevasion … disease, kidney disease, and breast cancer 2) Save lives by manufacturing at scale - Deliver… Cancer cell-derived extracellular vesicles (EVs) have previously been shown to contribute to pre…
- Email:
- j.wolfram@uq.edu.au
Associate Professor Joy Wolfram leads a nanomedicine and extracellular vesicle research program with the goal of developing innovative approaches that bring the next generation of treatments and diagnostics directly to the clinic. She has joint appointments in the School of Chemical Engineering and …
-
Senior Lecturer
School of Chemistry and Molecular BiosciencesFaculty of ScienceSenior Research Fellow
Frazer InstituteFaculty of MedicineMatched phrases in profile:
Everything in moderation: lessons learned by exploiting moderate replication stress in cancer… Targeting replication stress in cancer… Laser capture microdissection to empower cancer discoveries, improve diagnosis, treatment and outcomes in amyloidosis patients… all cellular life. In cancer cells, replication is corrupted and replication forks frequently stall… responsible for increased mutagenesis and loss of genome integrity in human cancers. The molecular…
- Email:
- mathew.jones@uq.edu.au
- Ph:
- +61 7 336 54878
-
Honorary Fellow
School of Biomedical SciencesFaculty of MedicineMatched phrases in profile:
Therapeutic Opportunity in Cancers with Poor Survival… Complex neoantigen prediction in cancers… genome sequencing technologies in biomedical research. In particular large cancer research…
Biological Sciences; Medical and Health Sciences; Oncology and Carcinogenesis; Genetics; Cancer Genetics; Genomics; Biological Sciences; Bioinformatics and computational biology; Cancer genetics; Oncology and carcinogenesis; Biomedical and Clinical Sciences; Genomics; Genetics;- Email:
- v.addala@uq.edu.au
Research officer, Medical Genomics
QIMR Berghofer Medical Research Institute
My research addressed the challenges related to key genomic components in tumour-immune editing variation in cancers with poor survival and predicting the responses to cancer immunotherapies. Characterizing genomic determinants in underlying response and resistance to cancer immunotherapy. Through w …
